[go: up one dir, main page]

DK8685A - METHOD FOR PREPARING 1ALFA, 25-HYDROXYLERED VITAMIN D2 AND RELATED COMPOUNDS - Google Patents

METHOD FOR PREPARING 1ALFA, 25-HYDROXYLERED VITAMIN D2 AND RELATED COMPOUNDS Download PDF

Info

Publication number
DK8685A
DK8685A DK8685A DK8685A DK8685A DK 8685 A DK8685 A DK 8685A DK 8685 A DK8685 A DK 8685A DK 8685 A DK8685 A DK 8685A DK 8685 A DK8685 A DK 8685A
Authority
DK
Denmark
Prior art keywords
vitamin
preparing
hydroxylered
1alfa
derivatives
Prior art date
Application number
DK8685A
Other languages
Danish (da)
Other versions
DK171397B1 (en
DK8685D0 (en
Inventor
Hector F Deluca
Us Heinrich K Schnoes
Rafal R Sicinski
Yoko Tanaka
Original Assignee
Wisconsin Alumni Res Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wisconsin Alumni Res Found filed Critical Wisconsin Alumni Res Found
Publication of DK8685A publication Critical patent/DK8685A/en
Publication of DK8685D0 publication Critical patent/DK8685D0/en
Application granted granted Critical
Publication of DK171397B1 publication Critical patent/DK171397B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/02Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00Drugs for genital or sexual disorders; Contraceptives
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/12Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18Radicals substituted by singly bound oxygen or sulfur atoms
    • C07D317/24Radicals substituted by singly bound oxygen or sulfur atoms esterified
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07JSTEROIDS
    • C07J71/00Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0036Nitrogen-containing hetero ring
    • C07J71/0042Nitrogen only

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Nutrition Science (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Steroid Compounds (AREA)

Abstract

Previously unknown derivatives of vitamin D2 and, more especially, 1α,25-dihydroxylated compounds of the vitamin D series. A process is also provided for preparing these derivatives, as are certain intermediates for this. The invention provides 1α,25- dihydroxyvitamin D2 derivatives, and acylates thereof, which can be used as replacement for vitamin D3 or D2, or for various of the known vitamin metabolites of the vitamins, for their various purposes for remedying pathological states in connection with calcium metabolism and bone diseases which are associated therewith.
DK008685A 1983-05-09 1985-01-08 24-Epi-1alpha,25-dihydroxylated vitamin D2 derivatives, and preparations for pharmaceutical use which comprises these derivatives DK171397B1 (en)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US49286383A 1983-05-09 1983-05-09
US49286383 1983-05-09
US60732784A 1984-05-04 1984-05-04
US60732784 1984-05-04
US8400714 1984-05-09
PCT/US1984/000714 WO1984004527A1 (en) 1983-05-09 1984-05-09 PROCESS FOR THE PREPARATION OF 1alpha,25-DIHYDROXYLATED VITAMIN D2 AND RELATED COMPOUNDS

Publications (3)

Publication Number Publication Date
DK8685A true DK8685A (en) 1985-01-08
DK8685D0 DK8685D0 (en) 1985-01-08
DK171397B1 DK171397B1 (en) 1996-10-14

Family

ID=27050897

Family Applications (3)

Application Number Title Priority Date Filing Date
DK008685A DK171397B1 (en) 1983-05-09 1985-01-08 24-Epi-1alpha,25-dihydroxylated vitamin D2 derivatives, and preparations for pharmaceutical use which comprises these derivatives
DK198801845A DK172567B1 (en) 1983-05-09 1988-04-06 3,5-cyclovitamin D2 derivative intermediates for use in the preparation of 1alpha, 25-dihydroxylated vitamin D2 derivatives
DK199101832A DK172733B1 (en) 1983-05-09 1991-11-07 25-oxovitamin D2 derivative intermediates for use in the preparation of 1alpha, 25-dihydroxylated vitamin D2 derivatives

Family Applications After (2)

Application Number Title Priority Date Filing Date
DK198801845A DK172567B1 (en) 1983-05-09 1988-04-06 3,5-cyclovitamin D2 derivative intermediates for use in the preparation of 1alpha, 25-dihydroxylated vitamin D2 derivatives
DK199101832A DK172733B1 (en) 1983-05-09 1991-11-07 25-oxovitamin D2 derivative intermediates for use in the preparation of 1alpha, 25-dihydroxylated vitamin D2 derivatives

Country Status (7)

Country Link
JP (3) JPH02288873A (en)
AU (1) AU568549B2 (en)
CH (1) CH665834A5 (en)
DE (4) DE3490215T (en)
DK (3) DK171397B1 (en)
NL (1) NL193245C (en)
WO (1) WO1984004527A1 (en)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH672920A5 (en) * 1984-10-04 1990-01-15 Wisconsin Alumni Res Found
EP0211863B1 (en) * 1985-01-17 1992-12-30 Wisconsin Alumni Research Foundation Vitamin d derivatives and methods for preparing same
US5104864A (en) * 1988-08-02 1992-04-14 Bone Care International, Inc. Method for treating and preventing loss of bone mass
CA1341408C (en) * 1988-08-02 2002-12-10 Charles W. Bishop Method for treating and preventing loss of bone mass
US4973584A (en) * 1989-03-09 1990-11-27 Deluca Hector F Novel 1α-hydroxyvitamin D2 epimer and derivatives
JP2645130B2 (en) * 1989-03-31 1997-08-25 日清製粉株式会社 Steroid derivatives
GB8914963D0 (en) * 1989-06-29 1989-08-23 Leo Pharm Prod Ltd Chemical compounds
IN171449B (en) * 1990-02-14 1992-10-17 Wisconsin Alumni Res Found
US5795882A (en) * 1992-06-22 1998-08-18 Bone Care International, Inc. Method of treating prostatic diseases using delayed and/or sustained release vitamin D formulations
ES2170069T3 (en) * 1992-06-22 2002-08-01 Bone Care Int Inc 1-ALFA-HYDROXIPREVITAMINE D FOR ORAL ADMINISTRATION.
US5763429A (en) * 1993-09-10 1998-06-09 Bone Care International, Inc. Method of treating prostatic diseases using active vitamin D analogues
US6242434B1 (en) 1997-08-08 2001-06-05 Bone Care International, Inc. 24-hydroxyvitamin D, analogs and uses thereof
US6573256B2 (en) 1996-12-30 2003-06-03 Bone Care International, Inc. Method of inhibiting angiogenesis using active vitamin D analogues
US6503893B2 (en) 1996-12-30 2003-01-07 Bone Care International, Inc. Method of treating hyperproliferative diseases using active vitamin D analogues
US6566353B2 (en) 1996-12-30 2003-05-20 Bone Care International, Inc. Method of treating malignancy associated hypercalcemia using active vitamin D analogues
HUP0002454A2 (en) 1997-02-13 2000-12-28 Bone Care International, Inc. Targeted therapeutic delivery of vitamin d compounds
WO2002006218A2 (en) 2000-07-18 2002-01-24 Bone Care International, Inc. STABILIZED 1α-HYDROXY VITAMIN D
US7148211B2 (en) 2002-09-18 2006-12-12 Genzyme Corporation Formulation for lipophilic agents
US7094775B2 (en) 2004-06-30 2006-08-22 Bone Care International, Llc Method of treating breast cancer using a combination of vitamin D analogues and other agents
EP3026042B1 (en) 2008-03-12 2019-10-09 OPKO Ireland Global Holdings, Limited Stabilized 1,25-dihydroxyvitamin d2 and method of making same

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4260549A (en) * 1979-05-21 1981-04-07 Wisconsin Alumni Research Foundation Process for preparing 1α-hydroxylated compounds
US4267117A (en) * 1978-06-19 1981-05-12 The Upjohn Company Compounds and process
US4269777A (en) * 1979-05-21 1981-05-26 Wisconsin Alumni Research Foundation Isotopically labeled vitamin D derivatives and processes for preparing same

Also Published As

Publication number Publication date
JPH0339505B2 (en) 1991-06-14
JPH02288854A (en) 1990-11-28
DK172567B1 (en) 1999-01-18
CH665834A5 (en) 1988-06-15
DK171397B1 (en) 1996-10-14
JPH02288873A (en) 1990-11-28
DE3448412C2 (en) 1991-12-12
WO1984004527A1 (en) 1984-11-22
JPH02288829A (en) 1990-11-28
DE3448360C2 (en) 1991-10-02
DK183291D0 (en) 1991-11-07
NL8420137A (en) 1985-04-01
JPH0610188B2 (en) 1994-02-09
AU3011584A (en) 1984-12-04
DK172733B1 (en) 1999-06-21
DK184588D0 (en) 1988-04-06
AU568549B2 (en) 1988-01-07
JPH0651624B2 (en) 1994-07-06
NL193245B (en) 1998-12-01
DK184588A (en) 1988-04-06
DE3490215C2 (en) 1991-07-25
NL193245C (en) 1999-04-02
DE3490215T (en) 1985-05-15
DK183291A (en) 1991-11-07
DK8685D0 (en) 1985-01-08

Similar Documents

Publication Publication Date Title
DK8685A (en) METHOD FOR PREPARING 1ALFA, 25-HYDROXYLERED VITAMIN D2 AND RELATED COMPOUNDS
AR240990A1 (en) PROCEDURE FOR THE SEPARATION OF MOLECULES OF BIOLOGICAL INTEREST, FROM A MIXTURE THAT CONTAINS THEM. "
ES514814A0 (en) A METHOD FOR THE PRODUCTION OF AN ENRICHED PROTEIN FRACTION.
BR8107071A (en) HEART VALVE FOR PROSTHESIS
ES527986A0 (en) PROCEDURE FOR THE PRODUCTION OF DERIVATIVES OF 1-AZOLIL-2-ARIL-3-FLUORO-ALCAN-2-OL.
ES2018319B3 (en) PROCEDURE FOR THE OBTAINING OF ALIPHATIC DIISOCYANATES (CYCLE).
MX6497E (en) PROCEDURE FOR THE PRODUCTION OF MICROCAPSULES CONTAINING MICROORGANISMS CONSTITUENT FROM INTESTINAL FLORA
AR223422A1 (en) PROCEDURE FOR THE STANDARD MANUFACTURE OF FOOTWEAR
ES503308A0 (en) A PROCEDURE FOR THE PREPARATION OF NEW PIRAZIMIL-1,2,4 OXADIAZOLE-5-ONAS.
DK137083A (en) METHOD FOR PREPARING 26,26,26,27,27,27-HEXAFLUOR-1ALFA, 25-DIHYDROXYCHOLECALCIFEROL AND INTERMEDIATES FOR USE
ES8302652A2 (en) A PROCEDURE FOR THE PREPARATION OF PIRROL DERIVATIVES
DK156716C (en) METHOD OF PREPARING 1-FLUORED VITAMIN D COMPOUNDS OR 1-FLUOR-5,6-TRANS VITAMIN D COMPOUNDS OR 1-FLUOR-3,5-CYCLOVITAMIN D COMPOUNDS
DK37590D0 (en) METHOD OF INVESTIGATION FOR 1,25-DIHYDROXY VITAMIN D
DE3371785D1 (en) Novel crystal modifications, processes for their production, and pharmaceutical preparations containing them
DK559887D0 (en) PROCEDURE FOR THE PREPARATION OF CARBINOOL DERIVATIVES
ES518477A0 (en) PROCEDURE FOR THE PRODUCTION OF CHROMOGEN DIHYDROFUROPYRIDINONES.
DK504983A (en) PROCEDURE FOR PREPARING POLYENE COMPOUNDS
ES551636A0 (en) PROCEDURE FOR THE MANUFACTURE OF FRAMES OBTAINED FROM RIGID PLASTIC PROFILES, IN PARTICULAR FOR USE IN REFRIGERATORS
IT8021032A0 (en) SOLES FOR FOOTWEAR. PROCEDURE FOR THE PRODUCTION OF
IS2902A7 (en) Method for the preparation of 1,8-dihydroxy-10-acyl-9-anthrones, especially for the treatment of psoriasis
ES552205A0 (en) METHOD FOR THE MANUFACTURE OF FOOTWEAR
MX156026A (en) PROCEDURE FOR THE PRODUCTION OF 2,4-DIAMINO- (3,5-DIMETOXI 4-METOXIETOXI BENZIL) PIRIMIDINA
MX7343E (en) MICROBIOLOGICAL PROCEDURE FOR THE PRODUCTION OF L-SERINE
ES507064A0 (en) PROCEDURE FOR THE SEPARATION OF MIXED PEPELOT.
DE3850870D1 (en) Method for the production of beta substituted allylsilanes.

Legal Events

Date Code Title Description
B1 Patent granted (law 1993)
PBP Patent lapsed

Country of ref document: DK